Monday, September 28, 2020
Home Life Style Health & Fitness Common Chemotherapy Drug may Lead to Heart Failure: Study

Common Chemotherapy Drug may Lead to Heart Failure: Study

The drug also caused a wasting syndrome in the heart and the spleen

A chemotherapy drug, widely used for treatment of ovarian, bladder, lung, thyroid and stomach cancers, has the potential to cause heart toxicity that can lead to congestive heart failure, a study led by a professor of Indian origin, has found.

In the study, conducted on mice, doxorubicin induced fibrosis in the heart, increased the programmed cell death called apoptosis and impaired the pumping of the heart.

The drug also caused a wasting syndrome in the heart and the spleen.

The study, led by Ganesh Halade, Assistant Professor at the University of Alabama in the US, found that disruption of the metabolism that controls immune responses in the spleen and heart is vital for heart maintenance, repair and control of inflammation.

For the study, published in the American Journal of Physiology — Heart and Circulatory Physiology, the team used a mouse model to study the effect of doxorubicin on immunometabolism — the study of how metabolism regulates immune cell function.

A dysregulated immunometabolism impairs resolution of inflammation, and chronic, non-resolving inflammation can lead to advanced heart failure.

heart disease
Representational image. (IANS)

Halade’s team found that doxorubicin is also involved in the deleterious response to the spleen.

First, doxorubicin was shown to induce irreversible dysregulation that lowered the levels of enzymes in the left ventricle of the heart, which in turn reduced the levels of bioactive lipids mediators produced by these enzymes, mediators that usually would help resolve inflammation.

In the spleen, doxorubicin also poisoned a special group of marginal zone immune cells called CD169+ macrophages, causing the spleen to diminish in size.

It also caused an imbalance of the cell-signalling molecules called chemokines and cytokines, and this imbalance suggested suppressed defence capacity of spleen-leukocyte immune cells.

Specifically, the researchers found decreased levels of tumour necrosis factor-alpha in the spleen, and decreased levels of the immune-cells reparative marker MRC-1, also known as CD206, in the heart.

Thus, doxorubicin appears to have a splenocardiac impact in this non-cancer model, Halade said. (IANS)

STAY CONNECTED

19,135FansLike
362FollowersFollow
1,776FollowersFollow

Most Popular

7 Money Tips to Travel for Hard-line Backpackers

Travel is something that every millennial love to do, but most of the time it can also turn out to be very costly especially...

People Neglect Fear of COVID as Food Orders Outrush

If you are among those who are thrilled to once again see food delivery boys all around or plan to visit a restaurant and...

Demand for Indian Animation Witnesses a Substantial Growth

With demand for Indian animated content growing among global audiences, especially with children who are a significant consumer group for animations like cartoon shows,...

Treatment and Lifestyle Changes for a Healthy Heart

From the time the first Coronavirus case was recorded in China, to India's numbers crossing four million, COVID-19 has millions of lives under its...

The Vogue Change of Footwear in India

Covid-19 has changed consumer buying patterns across segments, ranging from FMCG, personal care, apparel to footwear. The change has also led manufacturers to take...

Daughters’ Day: Entertainment Industry Showers Their Little Girls With Love

From megastar Amitabh Bachchan to Ajay Devgn and Ayushmann Khurrana, several stars took to social media to shower their daughters with love on the...

When “Rehnaa Hai Terre Dil Mein” Released, it was Flop But Slowly Became Iconic: Madhavan

When Rehnaa Hai Terre Dil Mein released in 2001, the film failed to create sparks at the box office. What remained with the viewers...

This is How NASA is Preparing Astronauts for Next Moonwalks in 2024

As NASA plans to return humans to the Moon in 2024 as part of the Artemis programme, the agency has already started preparing astronauts...

Recent Comments